Updates in Drug-Related Pneumonitis Due to Targeted Oncologic Therapies
An increasing number of newer targeted oncologic therapies approved for clinical use can cause drug-related pneumonitis. Drug-related pneumonitis can be difficult to diagnose and requires a high index of suspicion. This review serves as an update to a prior review in this journal about pneumonitis w...
| Published in: | Journal of Immunotherapy and Precision Oncology |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Innovative Healthcare Institute
2024-11-01
|
| Subjects: | |
| Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-24-12 |